APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Eye Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Dry Eye Syndrome Treatment Industry Research Report 2026

23 December 2025139 pages

Choose your research edition.

Industry ResearchDry Eye Syndrome Treatment Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Eye Syndrome Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Dry Eye Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Eye Syndrome Treatment Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Eye Syndrome Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Dry Eye Syndrome Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Dry Eye Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Dry Eye Syndrome Treatment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Dry Eye Syndrome Treatment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Dry Eye Syndrome Treatment include Sun Pharmaceutical, Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, Alcon, AbbVie, URSAPHARM and Thea pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Dry Eye Syndrome Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Dry Eye Syndrome Treatment Market by Company

Sun Pharmaceutical

Johnson & Johnson

Novartis

United Laboratories

Jianfeng Group

Alcon

AbbVie

URSAPHARM

Thea pharmaceuticals

SIMILASAN

Santen Pharma

Rohto

Prestige Consumer Healthcare

OmniVision Pharma

LION

Kenvue (VISINE)

Bausch & Lomb

Akorn

Dry Eye Syndrome Treatment Segment by Type

Liquid Wipes

Liquid Drops

Eye Ointment

Gel

Other

Dry Eye Syndrome Treatment Segment by Application

Clinic

Hospital

Home Care

Dry Eye Syndrome Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Dry Eye Syndrome Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Dry Eye Syndrome Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Dry Eye Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dry Eye Syndrome Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Dry Eye Syndrome Treatment Sales (k units) of Manufacturers (2021-2026) Table 7. Global Dry Eye Syndrome Treatment Sales Market Share by Manufacturers (2021-2026) Table 8. Global Dry Eye Syndrome Treatment Revenue of Manufacturers (2021-2026) Table 9. Global Dry Eye Syndrome Treatment Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Dry Eye Syndrome Treatment Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Dry Eye Syndrome Treatment Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Dry Eye Syndrome Treatment, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Dry Eye Syndrome Treatment, Product Type & Application Table 14. Global Dry Eye Syndrome Treatment Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Dry Eye Syndrome Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sun Pharmaceutical Company Information Table 19. Sun Pharmaceutical Business Overview Table 20. Sun Pharmaceutical Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Sun Pharmaceutical Dry Eye Syndrome Treatment Product Portfolio Table 22. Sun Pharmaceutical Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson Dry Eye Syndrome Treatment Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Novartis Company Information Table 29. Novartis Business Overview Table 30. Novartis Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Novartis Dry Eye Syndrome Treatment Product Portfolio Table 32. Novartis Recent Developments Table 33. United Laboratories Company Information Table 34. United Laboratories Business Overview Table 35. United Laboratories Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. United Laboratories Dry Eye Syndrome Treatment Product Portfolio Table 37. United Laboratories Recent Developments Table 38. Jianfeng Group Company Information Table 39. Jianfeng Group Business Overview Table 40. Jianfeng Group Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Jianfeng Group Dry Eye Syndrome Treatment Product Portfolio Table 42. Jianfeng Group Recent Developments Table 43. Alcon Company Information Table 44. Alcon Business Overview Table 45. Alcon Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Alcon Dry Eye Syndrome Treatment Product Portfolio Table 47. Alcon Recent Developments Table 48. AbbVie Company Information Table 49. AbbVie Business Overview Table 50. AbbVie Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. AbbVie Dry Eye Syndrome Treatment Product Portfolio Table 52. AbbVie Recent Developments Table 53. URSAPHARM Company Information Table 54. URSAPHARM Business Overview Table 55. URSAPHARM Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. URSAPHARM Dry Eye Syndrome Treatment Product Portfolio Table 57. URSAPHARM Recent Developments Table 58. Thea pharmaceuticals Company Information Table 59. Thea pharmaceuticals Business Overview Table 60. Thea pharmaceuticals Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Thea pharmaceuticals Dry Eye Syndrome Treatment Product Portfolio Table 62. Thea pharmaceuticals Recent Developments Table 63. SIMILASAN Company Information Table 64. SIMILASAN Business Overview Table 65. SIMILASAN Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. SIMILASAN Dry Eye Syndrome Treatment Product Portfolio Table 67. SIMILASAN Recent Developments Table 68. Santen Pharma Company Information Table 69. Santen Pharma Business Overview Table 70. Santen Pharma Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Santen Pharma Dry Eye Syndrome Treatment Product Portfolio Table 72. Santen Pharma Recent Developments Table 73. Rohto Company Information Table 74. Rohto Business Overview Table 75. Rohto Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Rohto Dry Eye Syndrome Treatment Product Portfolio Table 77. Rohto Recent Developments Table 78. Prestige Consumer Healthcare Company Information Table 79. Prestige Consumer Healthcare Business Overview Table 80. Prestige Consumer Healthcare Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Prestige Consumer Healthcare Dry Eye Syndrome Treatment Product Portfolio Table 82. Prestige Consumer Healthcare Recent Developments Table 83. OmniVision Pharma Company Information Table 84. OmniVision Pharma Business Overview Table 85. OmniVision Pharma Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. OmniVision Pharma Dry Eye Syndrome Treatment Product Portfolio Table 87. OmniVision Pharma Recent Developments Table 88. LION Company Information Table 89. LION Business Overview Table 90. LION Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. LION Dry Eye Syndrome Treatment Product Portfolio Table 92. LION Recent Developments Table 93. Kenvue (VISINE) Company Information Table 94. Kenvue (VISINE) Business Overview Table 95. Kenvue (VISINE) Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Kenvue (VISINE) Dry Eye Syndrome Treatment Product Portfolio Table 97. Kenvue (VISINE) Recent Developments Table 98. Bausch & Lomb Company Information Table 99. Bausch & Lomb Business Overview Table 100. Bausch & Lomb Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolio Table 102. Bausch & Lomb Recent Developments Table 103. Akorn Company Information Table 104. Akorn Business Overview Table 105. Akorn Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Akorn Dry Eye Syndrome Treatment Product Portfolio Table 107. Akorn Recent Developments Table 108. Global Dry Eye Syndrome Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Dry Eye Syndrome Treatment Sales by Region (2021-2026) & (k units) Table 110. Global Dry Eye Syndrome Treatment Sales Market Share by Region (2021-2026) Table 111. Global Dry Eye Syndrome Treatment Sales by Region (2027-2032) & (k units) Table 112. Global Dry Eye Syndrome Treatment Sales Market Share by Region (2027-2032) Table 113. Global Dry Eye Syndrome Treatment Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2021-2026) Table 115. Global Dry Eye Syndrome Treatment Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2027-2032) Table 117. North America Dry Eye Syndrome Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 119. North America Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 120. North America Dry Eye Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Dry Eye Syndrome Treatment Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Dry Eye Syndrome Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 124. Europe Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 125. Europe Dry Eye Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Dry Eye Syndrome Treatment Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Dry Eye Syndrome Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Dry Eye Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Dry Eye Syndrome Treatment Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Dry Eye Syndrome Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 134. South America Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 135. South America Dry Eye Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Dry Eye Syndrome Treatment Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Dry Eye Syndrome Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Dry Eye Syndrome Treatment Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Dry Eye Syndrome Treatment Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 143. Global Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 144. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2026) Table 145. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2027-2032) Table 146. Global Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 149. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 150. Global Dry Eye Syndrome Treatment Price by Type (2021-2026) & (USD/unit) Table 151. Global Dry Eye Syndrome Treatment Price by Type (2027-2032) & (USD/unit) Table 152. Global Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 153. Global Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 154. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2026) Table 155. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2027-2032) Table 156. Global Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 159. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 160. Global Dry Eye Syndrome Treatment Price by Application (2021-2026) & (USD/unit) Table 161. Global Dry Eye Syndrome Treatment Price by Application (2027-2032) & (USD/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Dry Eye Syndrome Treatment Distributors List Table 165. Dry Eye Syndrome Treatment Customers List Table 166. Dry Eye Syndrome Treatment Industry Trends Table 167. Dry Eye Syndrome Treatment Industry Drivers Table 168. Dry Eye Syndrome Treatment Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Dry Eye Syndrome Treatment Product Image Figure 5. Global Dry Eye Syndrome Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Dry Eye Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 7. Global Dry Eye Syndrome Treatment Sales (2021-2032) & (k units) Figure 8. Global Dry Eye Syndrome Treatment Average Price (USD/unit) & (2021-2032) Figure 9. Liquid Wipes Product Image Figure 10. Liquid Drops Product Image Figure 11. Eye Ointment Product Image Figure 12. Gel Product Image Figure 13. Other Product Image Figure 14. Clinic Product Image Figure 15. Hospital Product Image Figure 16. Home Care Product Image Figure 17. Global Dry Eye Syndrome Treatment Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Dry Eye Syndrome Treatment, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Dry Eye Syndrome Treatment Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Dry Eye Syndrome Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Dry Eye Syndrome Treatment Sales by Region in 2025 Figure 23. Global Dry Eye Syndrome Treatment Revenue by Region in 2025 Figure 24. North America Dry Eye Syndrome Treatment Market Size by Country in 2025 Figure 25. North America Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 26. North America Dry Eye Syndrome Treatment Revenue Market Share by Country (2021-2032) Figure 27. United States Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Dry Eye Syndrome Treatment Market Size by Country in 2025 Figure 31. Europe Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 32. Europe Dry Eye Syndrome Treatment Revenue Market Share by Country (2021-2032) Figure 33. Germany Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Dry Eye Syndrome Treatment Market Size by Country in 2025 Figure 44. Asia Pacific Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Dry Eye Syndrome Treatment Revenue Market Share by Country (2021-2032) Figure 46. China Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Dry Eye Syndrome Treatment Market Size by Country in 2025 Figure 55. South America Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 56. South America Dry Eye Syndrome Treatment Revenue Market Share by Country (2021-2032) Figure 57. Brazil Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Dry Eye Syndrome Treatment Market Size by Country in 2025 Figure 61. Middle East and Africa Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Dry Eye Syndrome Treatment Revenue Market Share by Country (2021-2032) Figure 63. Egypt Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Dry Eye Syndrome Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2032) Figure 69. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2032) Figure 70. Global Dry Eye Syndrome Treatment Price (USD/unit) by Type (2021-2032) Figure 71. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2032) Figure 72. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2032) Figure 73. Global Dry Eye Syndrome Treatment Price (USD/unit) by Application (2021-2032) Figure 74. Dry Eye Syndrome Treatment Value Chain Figure 75. Dry Eye Syndrome Treatment Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Dry Eye Syndrome Treatment Industry Opportunities and Challenges

Scope & coverage.

Types
  • Liquid Wipes
  • Liquid Drops
  • Eye Ointment
  • Gel
  • Other
Applications
  • Clinic
  • Hospital
  • Home Care
Companies covered
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • United Laboratories
  • Jianfeng Group
  • Alcon
  • AbbVie
  • URSAPHARM
  • Thea pharmaceuticals
  • SIMILASAN
  • Santen Pharma
  • Rohto
  • Prestige Consumer Healthcare
  • OmniVision Pharma
  • LION
  • Kenvue (VISINE)
  • Bausch & Lomb
  • Akorn

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Dry Eye Syndrome Treatment Market Size (2021-2032)
  4. 2.2.2 Global Dry Eye Syndrome Treatment Sales (2021-2032)
  5. 2.2.3 Global Dry Eye Syndrome Treatment Market Average Price (2021-2032)
  6. 2.3 Dry Eye Syndrome Treatment by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Liquid Wipes
  9. 2.3.3 Liquid Drops
  10. 2.3.4 Eye Ointment
  11. 2.3.5 Gel
  12. 2.3.6 Other
  13. 2.4 Dry Eye Syndrome Treatment by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Clinic
  16. 2.4.3 Hospital
  17. 2.4.4 Home Care
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Dry Eye Syndrome Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Dry Eye Syndrome Treatment Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Dry Eye Syndrome Treatment Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Dry Eye Syndrome Treatment Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Dry Eye Syndrome Treatment Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Dry Eye Syndrome Treatment, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Dry Eye Syndrome Treatment, Product Type & Application
  8. 3.8 Global Manufacturers of Dry Eye Syndrome Treatment, Established Date
  9. 3.9 Global Dry Eye Syndrome Treatment Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sun Pharmaceutical
  2. 4.1.1 Sun Pharmaceutical Company Information
  3. 4.1.2 Sun Pharmaceutical Business Overview
  4. 4.1.3 Sun Pharmaceutical Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sun Pharmaceutical Dry Eye Syndrome Treatment Product Portfolio
  6. 4.1.5 Sun Pharmaceutical Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson Dry Eye Syndrome Treatment Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Novartis
  14. 4.3.1 Novartis Company Information
  15. 4.3.2 Novartis Business Overview
  16. 4.3.3 Novartis Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis Dry Eye Syndrome Treatment Product Portfolio
  18. 4.3.5 Novartis Recent Developments
  19. 4.4 United Laboratories
  20. 4.4.1 United Laboratories Company Information
  21. 4.4.2 United Laboratories Business Overview
  22. 4.4.3 United Laboratories Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 United Laboratories Dry Eye Syndrome Treatment Product Portfolio
  24. 4.4.5 United Laboratories Recent Developments
  25. 4.5 Jianfeng Group
  26. 4.5.1 Jianfeng Group Company Information
  27. 4.5.2 Jianfeng Group Business Overview
  28. 4.5.3 Jianfeng Group Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Jianfeng Group Dry Eye Syndrome Treatment Product Portfolio
  30. 4.5.5 Jianfeng Group Recent Developments
  31. 4.6 Alcon
  32. 4.6.1 Alcon Company Information
  33. 4.6.2 Alcon Business Overview
  34. 4.6.3 Alcon Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Alcon Dry Eye Syndrome Treatment Product Portfolio
  36. 4.6.5 Alcon Recent Developments
  37. 4.7 AbbVie
  38. 4.7.1 AbbVie Company Information
  39. 4.7.2 AbbVie Business Overview
  40. 4.7.3 AbbVie Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 AbbVie Dry Eye Syndrome Treatment Product Portfolio
  42. 4.7.5 AbbVie Recent Developments
  43. 4.8 URSAPHARM
  44. 4.8.1 URSAPHARM Company Information
  45. 4.8.2 URSAPHARM Business Overview
  46. 4.8.3 URSAPHARM Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 URSAPHARM Dry Eye Syndrome Treatment Product Portfolio
  48. 4.8.5 URSAPHARM Recent Developments
  49. 4.9 Thea pharmaceuticals
  50. 4.9.1 Thea pharmaceuticals Company Information
  51. 4.9.2 Thea pharmaceuticals Business Overview
  52. 4.9.3 Thea pharmaceuticals Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Thea pharmaceuticals Dry Eye Syndrome Treatment Product Portfolio
  54. 4.9.5 Thea pharmaceuticals Recent Developments
  55. 4.10 SIMILASAN
  56. 4.10.1 SIMILASAN Company Information
  57. 4.10.2 SIMILASAN Business Overview
  58. 4.10.3 SIMILASAN Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 SIMILASAN Dry Eye Syndrome Treatment Product Portfolio
  60. 4.10.5 SIMILASAN Recent Developments
  61. 4.11 Santen Pharma
  62. 4.11.1 Santen Pharma Company Information
  63. 4.11.2 Santen Pharma Business Overview
  64. 4.11.3 Santen Pharma Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Santen Pharma Dry Eye Syndrome Treatment Product Portfolio
  66. 4.11.5 Santen Pharma Recent Developments
  67. 4.12 Rohto
  68. 4.12.1 Rohto Company Information
  69. 4.12.2 Rohto Business Overview
  70. 4.12.3 Rohto Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Rohto Dry Eye Syndrome Treatment Product Portfolio
  72. 4.12.5 Rohto Recent Developments
  73. 4.13 Prestige Consumer Healthcare
  74. 4.13.1 Prestige Consumer Healthcare Company Information
  75. 4.13.2 Prestige Consumer Healthcare Business Overview
  76. 4.13.3 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Product Portfolio
  78. 4.13.5 Prestige Consumer Healthcare Recent Developments
  79. 4.14 OmniVision Pharma
  80. 4.14.1 OmniVision Pharma Company Information
  81. 4.14.2 OmniVision Pharma Business Overview
  82. 4.14.3 OmniVision Pharma Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 OmniVision Pharma Dry Eye Syndrome Treatment Product Portfolio
  84. 4.14.5 OmniVision Pharma Recent Developments
  85. 4.15 LION
  86. 4.15.1 LION Company Information
  87. 4.15.2 LION Business Overview
  88. 4.15.3 LION Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 LION Dry Eye Syndrome Treatment Product Portfolio
  90. 4.15.5 LION Recent Developments
  91. 4.16 Kenvue (VISINE)
  92. 4.16.1 Kenvue (VISINE) Company Information
  93. 4.16.2 Kenvue (VISINE) Business Overview
  94. 4.16.3 Kenvue (VISINE) Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Kenvue (VISINE) Dry Eye Syndrome Treatment Product Portfolio
  96. 4.16.5 Kenvue (VISINE) Recent Developments
  97. 4.17 Bausch & Lomb
  98. 4.17.1 Bausch & Lomb Company Information
  99. 4.17.2 Bausch & Lomb Business Overview
  100. 4.17.3 Bausch & Lomb Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolio
  102. 4.17.5 Bausch & Lomb Recent Developments
  103. 4.18 Akorn
  104. 4.18.1 Akorn Company Information
  105. 4.18.2 Akorn Business Overview
  106. 4.18.3 Akorn Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Akorn Dry Eye Syndrome Treatment Product Portfolio
  108. 4.18.5 Akorn Recent Developments
5 Global Dry Eye Syndrome Treatment Market Scenario by Region
  1. 5.1 Global Dry Eye Syndrome Treatment Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Dry Eye Syndrome Treatment Sales by Region: 2021-2032
  3. 5.2.1 Global Dry Eye Syndrome Treatment Sales by Region: 2021-2026
  4. 5.2.2 Global Dry Eye Syndrome Treatment Sales by Region: 2027-2032
  5. 5.3 Global Dry Eye Syndrome Treatment Revenue by Region: 2021-2032
  6. 5.3.1 Global Dry Eye Syndrome Treatment Revenue by Region: 2021-2026
  7. 5.3.2 Global Dry Eye Syndrome Treatment Revenue by Region: 2027-2032
  8. 5.4 North America Dry Eye Syndrome Treatment Market Facts & Figures by Country
  9. 5.4.1 North America Dry Eye Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  11. 5.4.3 North America Dry Eye Syndrome Treatment Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Dry Eye Syndrome Treatment Market Facts & Figures by Country
  16. 5.5.1 Europe Dry Eye Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  18. 5.5.3 Europe Dry Eye Syndrome Treatment Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Dry Eye Syndrome Treatment Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Dry Eye Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Dry Eye Syndrome Treatment Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Dry Eye Syndrome Treatment Market Facts & Figures by Country
  41. 5.7.1 South America Dry Eye Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  43. 5.7.3 South America Dry Eye Syndrome Treatment Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Dry Eye Syndrome Treatment Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Dry Eye Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Dry Eye Syndrome Treatment Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Dry Eye Syndrome Treatment Sales by Type (2021-2032)
  2. 6.1.1 Global Dry Eye Syndrome Treatment Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2032)
  4. 6.2 Global Dry Eye Syndrome Treatment Revenue by Type (2021-2032)
  5. 6.2.1 Global Dry Eye Syndrome Treatment Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Dry Eye Syndrome Treatment Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Dry Eye Syndrome Treatment Sales by Application (2021-2032)
  2. 7.1.1 Global Dry Eye Syndrome Treatment Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2032)
  4. 7.2 Global Dry Eye Syndrome Treatment Revenue by Application (2021-2032)
  5. 7.2.1 Global Dry Eye Syndrome Treatment Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Dry Eye Syndrome Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Dry Eye Syndrome Treatment Value Chain Analysis
  2. 8.1.1 Dry Eye Syndrome Treatment Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Dry Eye Syndrome Treatment Production Mode & Process
  5. 8.2 Dry Eye Syndrome Treatment Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Dry Eye Syndrome Treatment Distributors
  8. 8.2.3 Dry Eye Syndrome Treatment Customers
9 Global Dry Eye Syndrome Treatment Analyzing Market Dynamics
  1. 9.1 Dry Eye Syndrome Treatment Industry Trends
  2. 9.2 Dry Eye Syndrome Treatment Industry Drivers
  3. 9.3 Dry Eye Syndrome Treatment Industry Opportunities and Challenges
  4. 9.4 Dry Eye Syndrome Treatment Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst